Skip to main content
. Author manuscript; available in PMC: 2018 Feb 22.
Published in final edited form as: Am J Prev Med. 2014 Oct 7;47(6):722–733. doi: 10.1016/j.amepre.2014.08.009

Table 3.

Adult vaccination coverage by birth status and language, United States, National Health Interview Survey 2012

U.S. born Foreign born
English-speaking
% (95% CI)
Non-English-speaking
% (95% CI)
English-speaking
% (95% CI)
Non-English-speaking
% (95% CI)
Influenza vaccination (2011–12 season)a
 18+ 40.5 (39.5, 41.6) 25.6 (17.6, 36.5)* 37.4 (35.0, 39.8) 26.0 (22.8, 29.7)*
Pneumococcal vaccination (ever received)
 18–64 with high-risk conditions 20.8 (19.6–22.0) 21.0 (11.2–35.9) 15.5 (12.9–18.5) 9.9 (6.6–14.5)*
 65+ 62.7 (61.0–64.3) --b 44.6 (40.0–49.1) 30.5 (24.4–37.4)*
Tetanus vaccination (past 10 yrs)
 18+ 65.1 (64.3–66.0) 53.2 (45.4–60.9)* 52.7 (50.8–54.6) 46.2 (43.1–49.2)*
Tetanus vaccination including pertussis vaccine (past 7 yrs)
 18+ 15.5 (14.8–16.3) 11.8 (6.6–20.2) 11.5 (10.2–13.0) 4.6 (3.3–6.5)*
Hepatitis A vaccination (≥ 2 doses)
 18–49 among travelers 19.8 (18.1–21.7) 25.2 (14.7–39.6) 19.3 (16.5–22.4) 10.9 (7.7–15.0)*
Hepatitis B vaccination (≥ 3 doses)
 18–49 37.2 (36.1–38.3) 38.9 (30.6–47.9) 34.6 (31.7–37.6) 16.0 (13.7–18.7)*
 18+ with diabetes 20.8 (18.8–22.9) --b 29.2 (23.0–36.3) 13.6 (9.0–20.2)*
Shingles vaccination (ever received)
 60+ 21.3 (20.2–22.5) --b 15.0 (12.1–18.4) 4.9 (2.8–8.5)*
Human papillomavirus vaccination (≥ 1 dose)
 18–26 Male 4.0 (2.8–5.6) --b --b --b
 18–26 Female 39.1 (36.2–42.0) 24.0 (14.1–37.7)* 17.3 (12.1–24.0) --b

Note: Boldface indicates significance.

Abbreviations: CI=Confidence interval.

a

Influenza vaccination coverage estimates are based on interviews conducted during September 2011 through June 2012, and vaccination received during August 2011 through May 2012.

b

Estimates are not reliable due to sample size < 30 or relative standard error (RSE) > 30%.

*

p < 0.05 by t-test (English-speaking vs. non-English-speaking).